CHAMPIONS ONCOLOGY, INC. Logo

CHAMPIONS ONCOLOGY, INC.

Oncology CRO accelerating drug development with PDX models and multi-omic data analytics.

CSBR | NDAQ

Overview

Corporate Details

ISIN(s):
US15870P3073
LEI:
549300O8WKLP8QEG5U47
Country:
United States of America
Address:
855 N. WOLFE STREET, 21205 BALTIMORE
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Champions Oncology, Inc. is a global contract research organization (CRO) specializing in end-to-end oncology drug development solutions. The company partners with pharmaceutical and biotech firms to accelerate research from discovery to clinical success. Its core offerings are built upon a proprietary, clinically relevant bank of over 1,400 patient-derived xenograft (PDX) models. This is integrated with a comprehensive multi-omic data platform, containing over two billion data points, accessible through its Lumin software for advanced analytics and visualization. Champions provides a suite of preclinical and clinical specialty testing services, including high-complexity flow cytometry, next-generation sequencing, histology, and radiopharmaceutical development, enabling data-driven decisions and biomarker discovery.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all CHAMPIONS ONCOLOGY, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CHAMPIONS ONCOLOGY, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CHAMPIONS ONCOLOGY, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
IntegraGen Logo
Genomic analysis & molecular diagnostics for cancer and rare diseases for researchers and labs.
France ALINT
INTENSITY THERAPEUTICS, INC. Logo
Develops injected therapies to kill tumors locally and activate a systemic immune response.
United States of America INTS
InterDigital, Inc. Logo
Develops and licenses essential wireless, video, and AI technologies for mobile devices and networks.
United States of America IDCC
Interworks Confidence Inc. Logo
Specialized staffing and recruitment for the game, entertainment, and manufacturing sectors.
Japan 7374
INTLOOP Inc. Logo
Offers consulting, tech, and HR solutions leveraging a vast freelance professional network.
Japan 9556
IntoCell, Inc. Logo
Develops and licenses proprietary ADC platform technologies for cancer & immune therapies.
South Korea 287840
Intracom S.A. Holdings Logo
A multinational group delivering IT solutions, defense electronics, and construction projects.
Greece INTRK
Inventionmed Spolka Akcyjna Logo
Develops VR medical simulators with haptic feedback for dermatology training.
Poland INM
Inventiva Logo
Clinical-stage biopharma developing oral therapies for fibrosis, oncology, & lysosomal disorders.
France IVA
A CRO advancing precision medicine via genomic analysis and clinical trial support services.
South Korea 216400

Talk to a Data Expert

Have a question? We'll get back to you promptly.